Kiromic Biopharma WKN: A3D7BN ISIN: US4976342042 Kürzel: KRBP

https://www.stocktitan.net/news/KRBP/kiromic-bio-pharma-s-deltacel-receives-fda-fast-track-4bd7eruzqjqr.html

https://ir.kiromic.com/news-releases/news-release-details/kiromic-biopharma-reports-consistent-favorable-safety

https://www.tipranks.com/news/company-announcements/kiromic-biopharma-strikes-2m-convertible-debt-deal-for-growth?utm_source=webullapp.com&utm_medium=referral

https://www.businesswire.com/news/home/20240214056810/en/Results-from-First-Patient-in-Kiromic-BioPharma%E2%80%99s-Deltacel-01-Clinical-Trial-Indicate-Tumor-Reduction-at-Two-Months

🍀

Ich habe sie aktuell nicht weiter verfolgt, aber zuletzt ließen sie sich nur noch OTC handeln. Daher kann ich dir leider nicht helfen.

Uii... das sind ja mal News 🤔

KRBP Suspended from Trading on Nasdaq Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14 https://www.businesswire.com/news/home/20230913097444/en/Kiromic-BioPharma-Common-Stock-to-Begin-Trading-on-the-OTC-Pink-Sheets-on-September-14

Kiromic BioPharma Submits SEC Filing Of Biotech AI Play; A Slide Deck With Artificial Intelligence - Diamond Artificial Intelligence Platform To Discover & Develop Cell Therapies In Lung Cancer In New Presentation https://www.benzinga.com/news/23/05/32513092/kiromic-biopharma-submits-sec-filing-of-biotech-ai-play-just-posted-a-slide-deck-with-artificial-int

What's Going On With Kiromic BioPharma Stock Wednesday https://www.benzinga.com/general/biotech/23/05/32190317/whats-going-on-with-kiromic-biopharma-stock-wednesday Kiromic BioPharma Inc (NASDAQ:KRBP) shares are gaining Wednesday morning. However there is no specific news today. During the session, the share price reached $9.22. Monday morning, the FDA authorized the company's Investigational New Drug (IND) application to initiate a Phase 1 trial to evaluate Deltacel (KB-GDT-01) for patients with non-small cell lung cancer (NSCLC). The company expects to start the trial in Q2 of 2023. Deltacel is the company's allogeneic, non- engineered, off-the-shelf Gamma Delta T-cell therapy. The company submitted the IND application in early April. Kiromic BioPharma stock is gaining on heavy volume, with a session volume of 3.6 million shares traded, compared to the trailing 100- day volume of 164.038K shares.

Was ist los hier? Wie lange dürfen wir in Deutschland nicht handeln? Warum ist sie ausgesetzt?

Läuft 👌

☕️

🍀

https://ir.kiromic.com/news-releases/news-release-details/kiromic-biopharma-announces-fda-authorization-ind-initiate-phase